Press release
Hematocrit Test Devices Market Size, Growth, Market Analysis, Segmentation, And Forecast To 2033
Hematocrit Test Devices Market Share
According to The Business Research Company's, The hematocrit test devices market size has grown strongly in recent years. It will grow from $4.35 billion in 2023 to $4.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to a rise in awareness regarding anemia, lack of iron and vitamins, increased incidence of chronic illnesses, the surge in government funding, and increase in the population.
The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $5.98 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing prevalence of anemia, growing cases of blood disorders, rise in geriatric population, growth in focus on health and fitness, and widening need for cardiovascular diagnostic equipment. Major trends in the forecast period include the introduction of cutting-edge solutions, advancement of technology in medical science, creation of new efficient and innovative products, technical developments in hematocrit testing, and advancements in the healthcare sector.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report
Market Drivers and Trends:
The growing cases of blood disorders are expected to propel the growth of the hematocrit test devices market going forward. A blood disorder is a condition that affects the components of human blood, including red blood cells, white blood cells, platelets, and blood plasma. Blood disorders are becoming more common due to several variables, including genetic predispositions, pollution in the environment, and lifestyle changes. Hematocrit test devices are primarily used to measure the volume percentage of red blood cells in whole blood, providing crucial information about the patient's hematological health. For instance, in January 2024, according to a report published by the American Cancer Society, a US-based non-profit organization, approximately 62,770 new cases of leukemia, encompassing all types, are anticipated in the United States in 2024, leading to an estimated 23,670 deaths. Among these cases, around 20,800 new instances of acute myeloid leukemia (AML) are expected, primarily affecting adults, with approximately 11,220 deaths attributed to AML, almost exclusively occurring in adult patients. Therefore, the growing cases of blood disorders are driving the growth of the hematocrit test devices market.
Major companies operating in the hematocrit test device market are developing innovative products, such as complete blood count (CBC) hematology analyzers, to provide quantitative and qualitative information about these blood cells. A complete blood count (CBC) hematology analyzer is an automated instrument used to measure and analyze various components of blood, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, launched the BC-700 hematology analyzer series, a complete blood count (CBC) hematology analyzer that incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. The BC-700 hematology analyzer, along with its counterparts BC-720, BC-760, and BC-780, constitutes a series tailored to empower medium-volume laboratories with cutting-edge diagnostic technologies akin to those found in premium products. The BC-700 Series is a more compact version of the high-end BC-6000 Series, built on the same platform and distinguished by Mindray's SF Cube 3D analysis technology. The SF Cube technology uses fluorescence and bi-angular laser scatter signals to analyze target cells in three dimensions.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp
Major Key Players of the Market:
F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.
Hematocrit Test Devices Market 2024 Key Insights:
• The hematocrit test devices market size is expected to see strong growth in the next few years. It will grow to $5.98 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%.
• Impact Of Blood Disorders On The Hematocrit Test Devices Market
• Innovative CBC Hematology Analyzers Revolutionize Blood Cell Analysis
• North America was the largest region in the hematocrit test devices market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15582&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (https://www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hematocrit Test Devices Market Size, Growth, Market Analysis, Segmentation, And Forecast To 2033 here
News-ID: 3714104 • Views: …
More Releases from The Business research company
C-X-C Chemokine Receptor Type 2 Market on Track for Strong Growth, Estimated to …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the C-X-C Chemokine Receptor Type 2 Market Through 2025?
There has been a significant expansion in the market for C-X-C chemokine receptor type 2 in the past few years. The market is projected to increase from $1.24 billion in 2024 to $1.38 billion…
Top Market Shifts Transforming the Coenzyme Q10 Market Landscape: Key Insights
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Coenzyme Q10 Market Through 2025?
The market size of coenzyme Q10 has seen impressive expansion in the past years, with predictions stating an increase from $0.74 billion in 2024 up to $0.84 billion in 2025, implying a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
2025-2034 Chimeric Antibody Market Evolution: Disruptions, Innovations, and Unta …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Chimeric Antibody Market Through 2025?
In recent times, there has been a swift expansion in the chimeric antibody market size. We can expect an increase from $12.27 billion in 2024 to $13.74 billion in 2025, reflecting a compound annual growth rate (CAGR)…
More Releases for Hematocrit
Impact Of Blood Disorders On The Hematocrit Test Devices Market: A Key Catalyst …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hematocrit Test Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for hematocrit test devices has experienced substantial growth in recent times, with predictions pointing to a rise from $4.63 billion in 2024 to $4.95 billion in 2025. This translates to a compound…
Impact Of Blood Disorders On The Hematocrit Test Devices Market: Key Factor Driv …
The Hematocrit Test Devices Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Hematocrit Test Devices Market Size During the Forecast Period?
The hematocrit test devices market has grown strongly in recent years. It is forecast to increase from $4.63 billion in 2024…
Impact Of Blood Disorders On The Hematocrit Test Devices Market: A Key Factor Sh …
What Are the Projections for the Size and Growth Rate of the Hematocrit Test Devices Market?
In the past few years, the market size for hematocrit test devices has seen robust growth. It is projected to expand from a value of $4.63 billion in 2024 to $4.95 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.9%. This significant growth during the historical period can be ascribed to heightened…
Hematocrit Test Devices Market Key Trends, Insights And Analysis Report 2024-203 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Hematocrit Test Devices Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $5.98 billion In 2028…
Hematocrit Tests Market | Abbott, Bio-Rad, Boule Diagnostics, Danaher
The global hematocrit tests market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the hematocrit tests market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Hematocrit Test Devices Market Key Insights, Profiling Companies and Growth Stra …
Hematocrit Test Devices Market - Overview
This report studies the current as well as future prospects of the global hematocrit test devices market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of hematocrit test devices and new players planning to enter the market. The report comprises an elaborate executive summary, along with a market snapshot, providing overall information on various segments considered in the…
